Dietary Reporting In The Amyloidoses
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app).
- Who it may be relevant to
- Registry conditions: Amyloidosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
DRITA Pilot Trial: Dietary Reporting in the Amyloidoses
Overview
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients Participants will be asked to: * Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
Interventions
- Other Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.
Primary outcome measures
- Adherence Rate [Time frame: 56 days]
Secondary outcome measures (1)
- Subsequent adherence rate [Time frame: 63 days (= 56 days + Week 10)]
Eligibility criteria
Inclusion criteria
- 18 years of age or older
- Diagnosed with any type of amyloidosis
- Speak, read and write in English
- Willing to use the MyFitnessPal app on their own smartphone
Exclusion criteria
- a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
- cognitive or perceptual disturbances
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- Karmanos Cancer Institute — Detroit
Identifiers
NCT: NCT05738005 · 2022-067